loader
Please Wait
Applying Filters...

Approved Drug Products of Incyte Corporation listed in the FDA Orange Book. Original Data : FDA Website

Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3PEMIGATINIB

02 1RETIFANLIMAB-DLWR

03 6RUXOLITINIB PHOSPHATE

04 1axatilimab-csfr

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass
Left Arrow
Right Arrow

01

Brand Name : NIKTIMVO

Boulder Peptide 2024
Not Confirmed
arrow

Brand Name : NIKTIMVO

Boulder Peptide 2024
Not Confirmed
arrow

Incyte Corporation

Dosage Form : INJECTABLE; INTRAVENOUS

Proprietary Name : NIKTIMVO

Dosage Strength : 50 MG/ML

Approval Date :

Application Number : 761411

RX/OTC/DISCN :

RLD :

TE Code :

blank

02

Brand Name : PEMAZYRE

Boulder Peptide 2024
Not Confirmed
arrow

Brand Name : PEMAZYRE

Boulder Peptide 2024
Not Confirmed
arrow

Incyte Corporation

Dosage Form : TABLET; ORAL

Proprietary Name : PEMAZYRE

Dosage Strength : 4.5MG

Approval Date : 2020-04-17

Application Number : 213736

RX/OTC/DISCN : RX

RLD : Yes

TE Code :

blank

03

Brand Name : PEMAZYRE

Boulder Peptide 2024
Not Confirmed
arrow

Brand Name : PEMAZYRE

Boulder Peptide 2024
Not Confirmed
arrow

Incyte Corporation

Dosage Form : TABLET; ORAL

Proprietary Name : PEMAZYRE

Dosage Strength : 9MG

Approval Date : 2020-04-17

Application Number : 213736

RX/OTC/DISCN : RX

RLD : Yes

TE Code :

blank

04

Brand Name : PEMAZYRE

Boulder Peptide 2024
Not Confirmed
arrow

Brand Name : PEMAZYRE

Boulder Peptide 2024
Not Confirmed
arrow

Incyte Corporation

Dosage Form : TABLET; ORAL

Proprietary Name : PEMAZYRE

Dosage Strength : 13.5MG

Approval Date : 2020-04-17

Application Number : 213736

RX/OTC/DISCN : RX

RLD : Yes

TE Code :

blank

05

Brand Name : ZYNYZ

Boulder Peptide 2024
Not Confirmed
arrow

Brand Name : ZYNYZ

Boulder Peptide 2024
Not Confirmed
arrow

Incyte Corporation

Dosage Form : INJECTABLE; INTRAVENOUS

Proprietary Name : ZYNYZ

Dosage Strength : 500MG/20ML(25MG/ML)

Approval Date :

Application Number : 761334

RX/OTC/DISCN :

RLD :

TE Code :

blank

06

Brand Name : JAKAFI

Boulder Peptide 2024
Not Confirmed
arrow

Brand Name : JAKAFI

Boulder Peptide 2024
Not Confirmed
arrow

Incyte Corporation

Dosage Form : TABLET; ORAL

Proprietary Name : JAKAFI

Dosage Strength : EQ 5MG BASE

Approval Date : 2011-11-16

Application Number : 202192

RX/OTC/DISCN : RX

RLD : Yes

TE Code :

blank

07

Brand Name : JAKAFI

Boulder Peptide 2024
Not Confirmed
arrow

Brand Name : JAKAFI

Boulder Peptide 2024
Not Confirmed
arrow

Incyte Corporation

Dosage Form : TABLET; ORAL

Proprietary Name : JAKAFI

Dosage Strength : EQ 10MG BASE

Approval Date : 2011-11-16

Application Number : 202192

RX/OTC/DISCN : RX

RLD : Yes

TE Code :

blank

08

Brand Name : JAKAFI

Boulder Peptide 2024
Not Confirmed
arrow

Brand Name : JAKAFI

Boulder Peptide 2024
Not Confirmed
arrow

Incyte Corporation

Dosage Form : TABLET; ORAL

Proprietary Name : JAKAFI

Dosage Strength : EQ 15MG BASE

Approval Date : 2011-11-16

Application Number : 202192

RX/OTC/DISCN : RX

RLD : Yes

TE Code :

blank

09

Brand Name : JAKAFI

Boulder Peptide 2024
Not Confirmed
arrow

Brand Name : JAKAFI

Boulder Peptide 2024
Not Confirmed
arrow

Incyte Corporation

Dosage Form : TABLET; ORAL

Proprietary Name : JAKAFI

Dosage Strength : EQ 20MG BASE

Approval Date : 2011-11-16

Application Number : 202192

RX/OTC/DISCN : RX

RLD : Yes

TE Code :

blank

10

Brand Name : OPZELURA

Boulder Peptide 2024
Not Confirmed
arrow

Brand Name : OPZELURA

Boulder Peptide 2024
Not Confirmed
arrow

Incyte Corporation

Dosage Form : CREAM; TOPICAL

Proprietary Name : OPZELURA

Dosage Strength : EQ 1.5% BASE

Approval Date : 2021-09-21

Application Number : 215309

RX/OTC/DISCN : RX

RLD : Yes

TE Code :

blank